Parkinson's Disease Therapeutics Pipeline Program (pre-clinical and clinical)

This program seeks to advance therapeutic development through pre-clinical and/or clinical testing of approaches addressing unmet needs of people with Parkinson’s disease (PD). The program is set up to benefit therapeutics with clear potential to prevent, stop, or delay disease progression or to reduce the burden of daily symptoms.

Funding: $250,000 to $2,000,000 total 

Duration: Pre clinical 1-2 years; clinical 2-3 years 

Research Authority due date: 7 days prior to submission 

LOI (required) due date: open 

Full proposal due date: 1112.25, 22.2.26, 23.4.26, 25.6.26